Technology commercialization, incubator and venture capital, and new venture performance

This study examines the effects of technology commercialization, incubator and venture capital supports on new venture performance from the resource-based view. This study uses regression analysis to test the hypotheses in a sample of 122 new ventures. The findings highlight the role of technology commercialization as a mediator between organizational resources, innovative capabilities, and new venture performance. Also, the empirical evidence indicates that incubator and venture capital supports moderate the effects of technology commercialization on the performance of new ventures. Finally, this study discusses managerial implications and highlights future research directions.     

Alignment or entrenchment? Corporate governance and cash holdings in growing firms

This study contends that the association between corporate cash holdings and corporate governance is subject to the investment environments that firms face. For example, firms with an abundance of investment opportunities have a strong incentive to hold cash in order to maintain their competitive positions. Shareholders accept high levels of cash holdings in such growing firms if corporate governance can protect their interests. This study examines the effects of corporate governance on cash holdings for a sample of high-tech firms. The results show that CEO ownership, the directorship of venture capitalists (VCs), and independent directors play critical roles in corporate cash policy. In addition, the boards are more effective when the firms' CEOs are also their founders or when VCs hold a large stake of company shares. The effects of corporate governance are more significant in younger firms while the effects of firm-specific economic variables are more significant in older firms in the sample.     

Corporate venturing: Insights from actual performance

Corporate innovation and the entrepreneurial strategies on which it is based are key challenges at the forefront of executive concerns. In order to establish some factual foundations amid the popular folklore which surrounds corporate innovation today, this study examines the actual factors that influence internal corporate venturing within the realm of a corporate entrepreneurship strategy. Data were collected from 145 internal corporate ventures (early-stage, middle-stage, and established-stage) operating in 72 firms headquartered in the midwestern United States. The results of this study are summarized herein and offer insights regarding some of the key correlates of corporate venturing performance.     

我国医药产业融资模式、问题与对策——基于全国57家医药上市企业的分析

资金匮乏已成为制约我国医药产业发展壮大的一个重要因素。本文基于对我国57家医药上市公司融资状况的分析发现,2007年我国医药企业的平均融资总额在23亿元左右。从融资结构来看,股权融资已成为医药企业融资的重要方式;从融资期限来看,医药企业以短期债务融资为主,在对医药产业融资存在问题进行分析的基础上,我们认为应该通过以下方面来促进我国医药产业的融资发展：建立多元化的融资渠道,降低企业融资成本;改变医药企业的短期融资倾向,鼓励发行中长期公司债券;通过产权市场来促进医药企业融资;加大对基础研究方面的投入．设立医药风险投资机构和风险投资基全。     

Venture capital in China: Past,present, and future

This article reviews the literature on venture capital in China and examines where China’s venture capital industry has been and where it is likely to go in the future. Since the 1980s, venture capital in China has grown steadily alongside the robust national economy. The future is likely to offer even greater opportunities, as entrepreneurs are encouraged and property rights improve. However, there will also be a period of transition as the market continues to mature and as new legal structures and commercial arrangements emerge. Venture capital in China has many interesting differences from that in Western countries. The venture capital industry is shaped by the institutional context and China is no exception to this. This article also examines some specific differences between the system in China and that of the United States. Future prospects for venture capital are also appraised as China continues its transition to a market economy.

创业板市场的IPO研究

本较为全面地研究了创业板的IPO市场。风险企业IPO是风险资本退出的有效渠道,风险型企业中的“内部投资”－风险投资家,将在企业IPO煌时间决策,定价和股权结构等方面发挥特别作用;同时邓创业板市场的定价,承销机制提出了一些建议。     

我国风险投资防稀释条款的应用及效用分析

当前,风险投资活动大多采用多轮投资的方式。如何在可能的后轮降价融资情况下保障自己的股份价值不被稀释,是防稀释条款的主要功能。但严厉的防稀释条款会对创业企业家造成损害,进而影响风险投资机构的利益。风险投资机构在设立防稀释条款时应避免设置完全棘轮条款,争取设置止损触发式期权和设置防稀释条款失效条款来激发创业企业家的创业激情;创业企业家则应争取设立＂持续融资＂条款和完善例外事项条款来抵消防稀释条款的消极作用。     

风险投资介入与企业创新：基于PSM模型的经验证据

“大众创业、万众创新”背景下，研究风险投资介入对企业创新绩效的影响具有重要理论与现实意义。以2010-2017年创业板公司为样本，采用倾向得分匹配法（PSM）模型,实证分析风险投资介入对企业创新绩效的影响,发现风险投资介入显著促进专利申请量，且对发明专利申请量和实用新型专利申请量有显著正向作用，而对外观设计专利影响并不显著。进一步考察不同背景和投资策略的风险投资对创新绩效的潜在影响，结果显示：与单独投资相比，联合投资对专利总申请量和发明专利申请量增加的促进作用更显著；与私营风险投资和外资风险投资相比，国有风险投资具有更强的发明取向和更长的投资时间，能显著促进发明专利等创新绩效提升，而私营和外资风险投资对公司创新绩效的影响不显著。     

Passion for entrepreneurship or passion for the product? A conjoint analysis of angel and VC decision-making

Passion is important to venture investors, but what specifically do they want entrepreneurs to be passionate about? This study theorizes that angel investors and venture capitalists consider both entrepreneurs' passion for activities related to the product or service the venture provides (i.e., product passion) and passion for founding and developing new ventures (i.e., entrepreneurial passion). We demonstrate that both types of passion become more appealing when the investor perceives that the entrepreneur is highly open and receptive to feedback, suggesting that openness to feedback mitigates potential concerns associated with passion in its extremes. We further find that venture investors differ in their consideration of passion; angel investors and venture capitalists with more investing experience place greater emphasis on the combination of product passion and openness to feedback, whereas those with more entrepreneurial experience emphasize the combination of entrepreneurial passion and openness to feedback.     

Blitzscaling: The good,the bad,and the ugly

Today’s disruptive innovations are driving the creation of numerous billion-dollar startups. Venture capitalists focus on these potentially disruptive technology startups and fund them furiously, advancing their speed of growth. The idea is to scale fast and seek huge returns for investors. Terms that define this type of aggressive scaling have recently developed in Silicon Valley. Unicorn is defined as a venture with a value of $1 billion, while a decacorn describes startups with a value of $10 billion. Another recent term is blitzscaling: funding a venture for extremely fast growth and prioritizing speed over efficiency in an environment of uncertainty. While blitzscaling is being used heavily by investors in Silicon Valley, we look at exactly what comprises this new phenomenon and how it is used in practice. We examine the concept, its stages, and its prevalence before reviewing the different examples of how the strategy has been implemented for success (the good), cases of its failure in practice (the bad), and the extreme cases of ethical compromise by ventures (the ugly). From these cases, we draw specific lessons that, if understood and appropriately addressed, would help new ventures effectively implement the strategy.